| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.94B | 118.01B | 110.17B | 103.73B | 107.36B | 108.04B |
| Gross Profit | 50.42B | 46.19B | 42.57B | 38.34B | 39.71B | 41.59B |
| EBITDA | 18.41B | 16.78B | 16.77B | 14.21B | 16.11B | 18.05B |
| Net Income | 18.50B | 9.30B | 9.98B | 8.13B | 10.40B | 10.75B |
Balance Sheet | ||||||
| Total Assets | 141.53B | 114.74B | 117.37B | 108.36B | 112.27B | 106.94B |
| Cash, Cash Equivalents and Short-Term Investments | 65.55B | 54.92B | 52.35B | 55.11B | 54.46B | 61.40B |
| Total Debt | 1.17B | 543.00M | 523.00M | 500.00M | 500.00M | 500.00M |
| Total Liabilities | 38.46B | 32.05B | 30.92B | 27.16B | 30.86B | 30.12B |
| Stockholders Equity | 103.05B | 82.68B | 86.43B | 81.19B | 81.38B | 76.80B |
Cash Flow | ||||||
| Free Cash Flow | 10.92B | 14.10B | 7.32B | 2.97B | 6.73B | 13.10B |
| Operating Cash Flow | 13.85B | 17.35B | 9.67B | 9.16B | 9.66B | 14.80B |
| Investing Cash Flow | -3.61B | -4.42B | -2.43B | -7.11B | -5.66B | -5.11B |
| Financing Cash Flow | -3.81B | -10.64B | -8.17B | -3.25B | -14.13B | 4.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥148.25B | 2.97 | 12.77% | 2.84% | 4.48% | 22.39% | |
75 Outperform | ¥59.74B | 6.56 | ― | 2.03% | -13.53% | 173.43% | |
72 Outperform | ¥102.86B | 8.23 | 22.46% | 4.06% | -8.93% | 48.98% | |
69 Neutral | ¥4.22T | 12.61 | ― | 3.27% | 4.02% | -41.52% | |
67 Neutral | ¥661.26B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
67 Neutral | ¥86.18B | 11.91 | ― | 4.76% | 1.81% | 9.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |